Kaisa Health Group Holdings Limited (HKG:0876)
Hong Kong · Delayed Price · Currency is HKD 0.1990
0.00 (0.00%)
At close: Feb 13, 2026
HKG:0876 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 166.42 | 185.36 | 185.88 | 191.5 | 209.63 | 183.81 | |
Revenue Growth (YoY) | -8.46% | -0.28% | -2.93% | -8.65% | 14.04% | -26.95% |
Cost of Revenue | 97.22 | 103.5 | 104.81 | 108.93 | 112.21 | 93.85 |
Gross Profit | 69.2 | 81.86 | 81.07 | 82.57 | 97.42 | 89.96 |
Selling, General & Admin | 86.53 | 93.59 | 107.4 | 132.54 | 157.3 | 111.44 |
Research & Development | 11.67 | 12.48 | 16.84 | - | - | - |
Other Operating Expenses | - | - | - | 17.43 | 17.22 | 20.45 |
Operating Expenses | 98.01 | 105.08 | 124.82 | 154.8 | 175.34 | 132.17 |
Operating Income | -28.81 | -23.23 | -43.74 | -72.24 | -77.93 | -42.21 |
Interest Expense | -0.6 | -0.78 | -3.67 | -7.73 | -8.18 | -1.09 |
Interest & Investment Income | 1.7 | 2.51 | 3.23 | 4.14 | 1.32 | 1.25 |
Currency Exchange Gain (Loss) | -0.29 | 0.35 | 0.11 | 0.78 | -1.81 | 3.47 |
Other Non Operating Income (Expenses) | -20.4 | -20.07 | 0.6 | -13.04 | 4.81 | 4.94 |
EBT Excluding Unusual Items | -48.39 | -41.21 | -43.48 | -88.08 | -81.79 | -33.63 |
Gain (Loss) on Sale of Investments | 11.24 | -9.77 | -21.3 | -12.07 | 66.02 | 21.66 |
Gain (Loss) on Sale of Assets | 0.19 | 0.19 | 68.96 | -0.01 | -2.21 | -0.97 |
Asset Writedown | - | - | - | -73.36 | - | - |
Other Unusual Items | 1.58 | 2.11 | 1.86 | 2.56 | 29.19 | -28.54 |
Pretax Income | -35.4 | -48.68 | 6.05 | -170.96 | 11.2 | -41.47 |
Income Tax Expense | 0.23 | 1.92 | -0.1 | 1.17 | 23.53 | -0.78 |
Earnings From Continuing Operations | -35.62 | -50.6 | 6.15 | -172.13 | -12.32 | -40.7 |
Net Income to Company | -35.62 | -50.6 | 6.15 | -172.13 | -12.32 | -40.7 |
Minority Interest in Earnings | 4.41 | 4.25 | 1.32 | 48.81 | 14.68 | 1 |
Net Income | -31.22 | -46.36 | 7.47 | -123.32 | 2.36 | -39.69 |
Net Income to Common | -31.22 | -46.36 | 7.47 | -123.32 | 2.36 | -39.69 |
Shares Outstanding (Basic) | 5,042 | 5,042 | 5,042 | 5,042 | 5,042 | 5,042 |
Shares Outstanding (Diluted) | 5,042 | 5,042 | 5,042 | 5,042 | 5,042 | 5,042 |
EPS (Basic) | -0.01 | -0.01 | 0.00 | -0.02 | 0.00 | -0.01 |
EPS (Diluted) | -0.01 | -0.01 | 0.00 | -0.02 | 0.00 | -0.01 |
Free Cash Flow | -28.6 | -39.05 | -46.7 | -71.96 | -136.6 | -38.7 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 | -0.01 |
Gross Margin | 41.58% | 44.16% | 43.61% | 43.11% | 46.47% | 48.94% |
Operating Margin | -17.31% | -12.53% | -23.53% | -37.72% | -37.17% | -22.96% |
Profit Margin | -18.76% | -25.01% | 4.02% | -64.40% | 1.13% | -21.59% |
Free Cash Flow Margin | -17.18% | -21.07% | -25.12% | -37.58% | -65.16% | -21.05% |
EBITDA | -21.91 | -15.56 | -33.22 | -50.07 | -60.68 | -28.46 |
EBITDA Margin | -13.16% | -8.39% | -17.87% | -26.15% | -28.95% | -15.48% |
D&A For EBITDA | 6.91 | 7.67 | 10.52 | 22.17 | 17.25 | 13.75 |
EBIT | -28.81 | -23.23 | -43.74 | -72.24 | -77.93 | -42.21 |
EBIT Margin | -17.31% | -12.53% | -23.53% | -37.72% | -37.17% | -22.96% |
Effective Tax Rate | - | - | - | - | 210.00% | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.